Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Contribution

Benign essential blepharospasm treated with botulinum toxin

A. Jan Berlin, M.D., Joyce H. Cassen, M.D., Garland DeNelsky, Ph.D., Maurice R. Hanson, M.D. and Patrick J. Sweeney, M.D.
Cleveland Clinic Journal of Medicine September 1987, 54 (5) 421-426;
A. Jan Berlin
Department of Ophthalmology, The Cleveland Clinic Foundation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joyce H. Cassen
Department of Ophthalmology, The Cleveland Clinic Foundation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Garland DeNelsky
Department of Psychiatry, The Cleveland Clinic Foundation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maurice R. Hanson
Department of Neurology, The Cleveland Clinic Foundation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick J. Sweeney
Department of Neurology, The Cleveland Clinic Foundation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Blepharospasm in 12 patients was graded according to its severity. Six patients also underwent neurological and psychological examinations. All were treated with periocular botulinum toxin injections, and all noted a reduction in spasm severity one week later. The effect lasted 60 to 90 days. The average improvement range was 2 gradations of spasm severity. Complications included a transient ptosis (two patients) and superficial punctate keratopathy (one patient). A psychological component—apparent secondary gain from the blepharospasm—was noted in three patients.

Index term
  • Eyelid diseases
  • drug therapy
  • Received August 1985.
  • Accepted May 1987.
  • Copyright © 1987 The Cleveland Clinic Foundation. All Rights Reserved.
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 54 (5)
Cleveland Clinic Journal of Medicine
Vol. 54, Issue 5
1 Sep 1987
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Benign essential blepharospasm treated with botulinum toxin
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
Please verify that you are a real person.
Citation Tools
Benign essential blepharospasm treated with botulinum toxin
A. Jan Berlin, Joyce H. Cassen, Garland DeNelsky, Maurice R. Hanson, Patrick J. Sweeney
Cleveland Clinic Journal of Medicine Sep 1987, 54 (5) 421-426;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Benign essential blepharospasm treated with botulinum toxin
A. Jan Berlin, Joyce H. Cassen, Garland DeNelsky, Maurice R. Hanson, Patrick J. Sweeney
Cleveland Clinic Journal of Medicine Sep 1987, 54 (5) 421-426;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A good death: is euthanasia the answer?
  • Polysomnographie, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients
  • Startle disease (hyperekplexia): a hereditary disorder with abnormal startle, falling spells, and attacks of spontaneous clonus
Show more Contribution

Similar Articles

Keywords

  • Eyelid diseases
  • Drug Therapy

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire